{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:06:42Z","timestamp":1787771202961,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"University of Washington Fred Hutch Center for AIDS Research","doi-asserted-by":"publisher","award":["P30 AI027757"],"award-info":[{"award-number":["P30 AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clml.2025.12.010","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T06:40:33Z","timestamp":1765694433000},"page":"e536-e541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HIV, HBV, and HCV Testing in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Experience From a Comprehensive Cancer Center"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2642-1690","authenticated-orcid":false,"given":"C. Natasha","family":"Kwendakwema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine F.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Nina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-0376","authenticated-orcid":false,"given":"Manoj P.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clml.2025.12.010_bib0001","first-page":"5","article-title":"Epidemiology of non-Hodgkin\u2019s lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.clml.2025.12.010_bib0002","series-title":"StatPearls","article-title":"Diffuse large B-cell lymphoma","author":"Padala","year":"2024"},{"issue":"8","key":"10.1016\/j.clml.2025.12.010_bib0003","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3851\/IMP1462","article-title":"Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study","volume":"14","author":"Bohlius","year":"2009","journal-title":"Antivir Ther"},{"issue":"5","key":"10.1016\/j.clml.2025.12.010_bib0004","first-page":"1256","article-title":"Hepatitis Virus-associated non-hodgkin lymphoma: pathogenesis and treatment strategies","volume":"11","author":"Zhang","year":"2023","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"10.1016\/j.clml.2025.12.010_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"25","key":"10.1016\/j.clml.2025.12.010_bib0006","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.clml.2025.12.010_bib0007","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1470-2045(10)70167-4","article-title":"Hepatitis B virus infection and risk of non-hodgkin lymphoma in South Korea: a cohort study","volume":"11","author":"Engels","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clml.2025.12.010_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100750","article-title":"How I treat diffuse large B-cell lymphoma","volume":"8","author":"Melchardt","year":"2023","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.clml.2025.12.010_bib0009","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcv.2013.03.010","article-title":"Risk of hepatitis B virus (HBV) reactivation in non-hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis","volume":"57","author":"Dong","year":"2013","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.clml.2025.12.010_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2018-04-848044","article-title":"Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy","volume":"133","author":"Kusumoto","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2025.12.010_bib0011","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","article-title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies","volume":"136","author":"Lalazar","year":"2007","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.clml.2025.12.010_bib0012","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0033-1345722","article-title":"Immunosuppression and HBV reactivation","volume":"33","author":"Shouval","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"24","key":"10.1016\/j.clml.2025.12.010_bib0013","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2025.12.010_bib0014","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/CCO.0b013e32832f3e04","article-title":"Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook","volume":"21","author":"Deeken","year":"2009","journal-title":"Curr Opin Oncol"},{"issue":"35","key":"10.1016\/j.clml.2025.12.010_bib0015","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1200\/JCO.22.00668","article-title":"Direct-acting antivirals as primary treatment for Hepatitis C virus-associated indolent Non-hodgkin lymphomas: the BArT study of the Fondazione Italiana Linfomi","volume":"40","author":"Merli","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clml.2025.12.010_bib0016","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/annonc\/mdx635","article-title":"From hepatitis C virus infection to B-cell lymphoma","volume":"29","author":"Couronn\u00e9","year":"2018","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.clml.2025.12.010_bib0017","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3324\/haematol.2009.005819","article-title":"Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance","volume":"94","author":"Ziakas","year":"2009","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.clml.2025.12.010_bib0018","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.clml.2025.12.010_bib0019","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"31","key":"10.1016\/j.clml.2025.12.010_bib0020","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1200\/JCO.20.01757","article-title":"Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO provisional clinical opinion update","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2025.12.010_bib0021","unstructured":"ARCHITECT HIV Ag\/ab combo package insert G2-6108\/R02."},{"issue":"1","key":"10.1016\/j.clml.2025.12.010_bib0022","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00277-015-2502-0","article-title":"Screening for viral hepatitis prior to rituximab chemotherapy","volume":"95","author":"Leonard","year":"2016","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.clml.2025.12.010_bib0023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10620-017-4850-1","article-title":"Practice patterns in Hepatitis B virus screening before cancer chemotherapy in a major US hospital network","volume":"63","author":"Kwak","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.clml.2025.12.010_bib0024","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cncr.30381","article-title":"Improvements in hepatitis B virus screening before rituximab therapy: a community-based, safety-net hospital experience","volume":"123","author":"Junus","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2025.12.010_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2022.11.024","article-title":"Patients treated with rituximab are poorly screened for hepatitis B infection: data from a low-incidence country","volume":"108","author":"Brakenhoff","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.clml.2025.12.010_bib0026","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jamaoncol.2018.6437","article-title":"Prevalence of Hepatitis B virus, Hepatitis C virus, and HIV infection among patients with newly diagnosed cancer from academic and community oncology practices","volume":"5","author":"Ramsey","year":"2019","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.clml.2025.12.010_bib0027","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1200\/JOP.2013.001215","article-title":"Hepatitis C virus screening in patients with cancer receiving chemotherapy","volume":"10","author":"Hwang","year":"2014","journal-title":"J Oncol Pract"},{"issue":"5","key":"10.1016\/j.clml.2025.12.010_bib0028","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JOP.2015.005116","article-title":"HIV testing in patients with cancer at the initiation of therapy at a large US Comprehensive Cancer center","volume":"11","author":"Hwang","year":"2015","journal-title":"J Oncol Pract"},{"issue":"10","key":"10.1016\/j.clml.2025.12.010_bib0029","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/hiv.12181","article-title":"Patients with AIDS-defining cancers are not universally screened for HIV: a 10-year retrospective analysis of HIV-testing practices in a Swiss university hospital","volume":"15","author":"Mosimann","year":"2014","journal-title":"HIV Med"},{"issue":"6","key":"10.1016\/j.clml.2025.12.010_bib0030","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMsa042088","article-title":"Expanded screening for HIV in the United States\u2013an analysis of cost-effectiveness","volume":"352","author":"Paltiel","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clml.2025.12.010_bib0031","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/2325957414524025","article-title":"What makes me screen for HIV? Perceived barriers and facilitators to conducting recommended routine HIV testing among primary care physicians in the southeastern United States","volume":"14","author":"White","year":"2015","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"4","key":"10.1016\/j.clml.2025.12.010_bib0032","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s10461-018-02385-5","article-title":"Barriers to HIV testing: patient and provider perspectives in the Deep South","volume":"23","author":"Wise","year":"2019","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.clml.2025.12.010_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279958","article-title":"Mapping hematologists' HIV testing behavior among lymphoma patients-A mixed-methods study","volume":"18","author":"Bogers","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clml.2025.12.010_bib0034","first-page":"408","article-title":"Prevalence of viremic Hepatitis C Virus infection by age, race\/ethnicity, and birthplace and disease awareness among viremic persons in the United States, 1999-2016","volume":"221","author":"Zou","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.clml.2025.12.010_bib0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/hep.27843","article-title":"Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area","volume":"62","author":"Hsu","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clml.2025.12.010_bib0036","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/hiv.12474","article-title":"Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis","volume":"18","author":"Henriquez-Camacho","year":"2017","journal-title":"HIV Med"},{"issue":"8","key":"10.1016\/j.clml.2025.12.010_bib0037","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1017\/S0950268818000870","article-title":"Implementing routine blood-borne virus testing for HCV, HBV and HIV at a London Emergency Department - uncovering the iceberg?","volume":"146","author":"Parry","year":"2018","journal-title":"Epidemiol Infect"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025043058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025043058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:17:47Z","timestamp":1776741467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025043058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2152265025043058"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.12.010","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV, HBV, and HCV Testing in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Experience From a Comprehensive Cancer Center","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}